ASHLAND INC. (ASH)
Sector: Wholesale-Chemicals & Allied Products
Industry: Chemicals - Specialty
Ashland Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | 75.39 | 79.50 | 74.00 | 76.62 | 1,696,578 |
| Nov 5, 2026 | 76.82 | 77.52 | 75.61 | 76.28 | 1,264,559 |
| Nov 4, 2026 | 73.54 | 76.48 | 73.26 | 76.44 | 1,036,582 |
| Nov 3, 2026 | 74.99 | 75.71 | 72.80 | 73.02 | 896,173 |
| Nov 2, 2026 | 75.62 | 76.32 | 74.19 | 74.19 | 639,441 |
| Oct 30, 2026 | 74.19 | 74.85 | 73.85 | 74.68 | 457,199 |
| Oct 29, 2026 | 73.24 | 74.49 | 72.95 | 74.38 | 545,472 |
| Oct 28, 2026 | 73.17 | 73.90 | 72.23 | 72.67 | 374,884 |
| Oct 27, 2026 | 72.26 | 73.23 | 72.03 | 72.78 | 339,046 |
| Oct 26, 2026 | 73.04 | 73.55 | 72.08 | 72.32 | 332,649 |
| Oct 23, 2026 | 72.95 | 73.47 | 72.11 | 72.99 | 427,340 |
| Oct 22, 2026 | 72.51 | 73.75 | 71.00 | 73.57 | 440,123 |
| Oct 21, 2026 | 71.65 | 72.44 | 71.10 | 72.14 | 407,764 |
| Oct 20, 2026 | 71.25 | 72.16 | 71.25 | 71.69 | 526,629 |
| Oct 19, 2026 | 71.59 | 71.99 | 71.00 | 71.19 | 343,466 |
| Oct 16, 2026 | 71.65 | 73.05 | 70.99 | 71.15 | 430,005 |
| Oct 15, 2026 | 71.31 | 71.97 | 70.80 | 71.59 | 457,057 |
| Oct 14, 2026 | 72.13 | 72.77 | 70.39 | 71.32 | 459,008 |
| Oct 13, 2026 | 71.20 | 73.06 | 70.63 | 72.65 | 388,856 |
| Oct 12, 2026 | 70.16 | 71.53 | 70.16 | 70.78 | 459,226 |
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Director | Grant/Award | 212 | $14.4K | Sep 30, 2026 | |
| Director | Grant/Award | 368 | $25.0K | Sep 30, 2026 | |
| SVP and CTO | Option Exercise | 10.4K | $719.5K | Sep 21, 2026 | |
| SVP and CTO | Automatic Sell | 3.6K | $251.9K | Sep 21, 2026 | |
| SVP and CTO | Option Exercise | 10.4K | -- | Sep 21, 2026 | |
| SVP and CTO | Grant/Award | 14.2K | -- | Sep 15, 2026 |
Insiders
- Chattopadhyay SanatDirector
- Bishop Steven DDirector
- MUSA OSAMA MSVP and CTO
- LAMPKIN ROBIN E.SVP, GC & Secretary
- Assis Alessandra FaccinSVP and GM, Life Sciences
- SPIZZO ALLEN ADirector
- Thomas Peter TDirector
- LOY BERTRANDDirector
- MINICUCCI JAMES P.SVP and GM, Personal Care
- NOVO GUILLERMOChair of the Board and CEO
Ashland Inc. provides additives and specialty ingredients worldwide.
It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. The Personal Care & Household segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. The Intermediates and Solvents segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone.
It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical.
The company was formerly known as Ashland Global Holdings Inc. Ashland Inc. was founded in 1924 and is based in Wilmington, Delaware.
13F filers report 52.46M shares, more than the 45.79M outstanding, so no percentage is shown. 13F reports lag by a quarter and shares lent to short sellers can be counted twice.
30d Avg
596.10K
60d Avg
637.95K
90d Avg
601.30K